You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 288 No. 6, August 14, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Psychiatry
 •Depression
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Depression Following Acute Myocardial Infarction

Robert M. Carney, PhD; Allan S. Jaffe, MD

JAMA. 2002;288:750-751.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Depression is a risk factor for mortality after acute myocardial infarction (MI), and it predicts a slow recovery and a poor quality of life.1-4 Nevertheless, only a minority of patients who are depressed after an MI receive treatment for their depression. In the past, the only available antidepressants had cardiotoxic effects and were contraindicated for many patients with heart disease, particularly older patients at risk for orthostatic hypotension and patients with left bundle branch block.5 Some of the older antidepressants also have proarrhythmic effects.6

The newer selective serotonin reuptake inhibitor (SSRI) antidepressants are free of cardiotoxic effects in relatively healthy depressed patients.7 However, because heart disease has remained a standard exclusion criterion in clinical trials of antidepressants, very little is actually known about the safety and efficacy of antidepressants for depressed patients with heart disease. Psychotherapy is a safe and effective alternative . . . [Full Text of this Article]

Author Affiliations: Department of Psychiatry, Washington University School of Medicine, St Louis, Mo (Dr Carney); and Departments of Medicine/Cardiology and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minn (Dr Jaffe).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable Angina
Alexander H. Glassman, Christopher M. O'Connor, Robert M. Califf, Karl Swedberg, Peter Schwartz, J. Thomas Bigger, Jr, K. Ranga Rama Krishnan, Louis T. van Zyl, J. Robert Swenson, Mitchell S. Finkel, Charles Landau, Peter A. Shapiro, Carl J. Pepine, Jack Mardekian, Wilma M. Harrison, and for the Sertraline Antidepressant Heart Attack Randomized Trial Group
JAMA. 2002;288(6):701-709.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Predictors of Depression Three Months After Cardiac Hospitalization
Schrader et al.
Psychosom. Med. 2004;66:514-520.
ABSTRACT | FULL TEXT  

Sertraline Is Safe for Treating Patients with Major Depression After ACS
Journal Watch Cardiology 2002;2002:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.